我们产生的多数抗体是与病毒表面蛋白血凝素的球状头部结合的。
Most of the antibodies we produce bind to the globular heads of a surface protein on the virus called haemagglutinin.
然而，结合效率在不同毒株间存在差异，而且这种差异部分决定于血凝素蛋白中的受体结合位点。
However, binding efficiency varies between flu strains, and that variation is partly determined by the receptor-binding site (RBS) within the hemagglutinin protein.
报道还指出，EB治疗是通过与流感病毒血凝素结合，抑制病毒复制，从而阻止了流感病毒与细胞的黏附。
Eb treatment inhibited viral replication by binding to influenza virus hemagglutinin, thereby preventing attachment of influenza virus to cells, the report indicates.
流感病毒血凝素受体结合位点的氨基酸可以影响受体结合特性。
Aminoacids in the receptor binding sites of hemagglutinin have been shown to be associated with the receptor binding specificity.
研究人员通过该方法设计出来的蛋白，能够结合到广泛流行性病毒1918H1N 1蛋白血凝素(HA)主干上的一个保守的表面区域。
The method was used to design proteins that bind a conserved surface patch on the stem of the influenza hemagglutinin (ha) from the 1918 H1N1 pandemic virus.
血凝素与细胞受体表面糖链的特异性结合与流感病毒的宿主范围也密切相关。
Hemagglutinin specificity binding with glycan chains receptor on cell surface determines the host range of influenza viruses.
血凝素与细胞受体表面糖链的特异性结合与流感病毒的宿主范围也密切相关。
Hemagglutinin specificity binding with glycan chains receptor on cell surface determines the host range of influenza viruses.
应用推荐